NITAG publications and updates:COVID-19 Booster vaccination: NACI updated its guidance on a first booster dose of COVID-19 vaccines in Canada. In particular: NACI has strengthened the following recommendations from ‘may’ to ‘should,’ so that now all adults 18 years of age and over are strongly recommended to receive a booster dose: A first ...

NITAG publications and updates:COVIFENZ: NACI recommends the Medicago Covifenz COVID-19 vaccine for use as a primary series in people 18 to 64 years of age. This is the first plantbased virus-like particle (VLP) vaccine authorized for use in Canada. Clinical trials show the Medicago Covifenz COVID-19 vaccine has a good safety profile and is...

Dear all, Please find below the GNN monthly update for February’ 22:NITAG publications and updates:COVID-19 booster Doses: ATAGI (Australia) recommends the use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years. The statement is available here. Of note, Pfizer vaccine is the only brand currently registered ...

Dear all, Best wishes to all of you for this new year! The year started with a first extraordinary SAGE meeting on January 19th which focused on major revision to the WHO SAGE Roadmap for Prioritizing Use of COVID-19 Vaccines. While the previous version of the Roadmap was developed in the context ofvaccine supply constraints, this updated ve...

Please find below the GNN monthly update for December’ 21:NITAG publications and updates:COVID-19 additional and booster Doses: NACI (Canada) has updated its booster recommendations.NACI strongly recommends a booster dose of an authorized mRNA COVID-19 vaccine should be offered at least 6 months after completion of a primary COVID19...

Dear all, Thank you all who could participate in the GNN webinar yesterday. It has been very fruitful to hear current situations on booster vaccination and timing for the booster dose as well as challenges on product specific vaccines. We also hope that you will make the most of the Sysvac registry. All the presentations are available here. The rec...

Please find below the GNN monthly update for November 21: NITAG publications and updates:COVID-19 additional and booster Doses: NACI (Canada) strongly recommends that populations at highest risk of waning protection following their primary series and at highest risk of severe COVID-19 illness should be offered a booster dose of an mRNA COVI...

Please find below the GNN monthly update for September’ 21:NITAG publications and updates:COVID-19 booster Dose: JCVI (UK) has issued updated advice on COVID-19 booster vaccination.The Belgian NITAG recommends an additional dose of mRNA COVID-19 vaccine for older adults (age cut-off: 65 years). The advice is available in French here...

NITAG publications and updates: COVID-19 extended primary series: HAS (France) has issued updated advice on booster vaccination with COMIRNATY mRNA vaccine. The NITAG recommends a booster dose for people aged 65+, health care workers and people living in close contact with an immunocompromised person. Norwegian National Institute of Public He...